Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Not Just for Diabetes: The Next Frontier for GLP-1 Agonists
Journal of the American Board of Family Medicine : JABFM;39(1)
A multi-functional oral small molecule targeting energy and lipid metabolism to treat obesity and related metabolic disorders
Science advances, 2026;12(34):eaed3119
GLP-1 receptor agonist therapy is associated with increased symptomatic remission in ulcerative colitis: a matched cohort study
Inflammatory bowel diseases, 2026
GLP-1 and GLP-1/GIP agonists in psoriasis: A real-world cohort study on healthcare resource usage
Journal of the European Academy of Dermatology and Venereology : JEADV, 2026
GLP-1 and dual GIP/GLP-1 receptor agonists’ psychopharmacology and putative neuropsychiatric associated effects: a Bradford Hill-informed, systematic, evaluation
Current psychiatry reports, 2026;28(1)
Effects of Incretin-Based Therapies on Testosterone Levels and Incretin Response in Men with Hypogonadism: A Systematic Literature Review Following PRISMA 2020 Guidelines
Pharmaceuticals (Basel, Switzerland), 2026;19(8)
Pharmacotherapy for Obstructive Sleep Apnea: From Pathophysiology to Emerging Treatments
Journal of clinical medicine, 2026;15(16)
Pharmacist-led medication therapy management improving medication adherence in a patient with type 2 diabetes: case report
Frontiers in medicine, 2026;13:1910565
Beyond Weight Loss: Glucagon-Like Peptide-1 Receptor Agonists and Antipsychotic Adherence in Schizophrenia
Cureus, 2026;18(8):e114933
Original rDNA Semaglutide Versus Synthetic Copies: Differences and Clinical Implications
Cureus, 2026;18(8):e114959
Pigmented purpura dermatosis associated with compounded semaglutide: A case report and literature review of medication-associated pigmented purpuric dermatosis
JAAD case reports, 2026;77:148-150
Response to Comment on Klein et al. Safety of Semaglutide After Dialysis Initiation: An Individual-Level Pooled Analysis
Diabetes care;49(9):e161-e162
Comment on Ostrominski et al. Comparative Effectiveness of Tirzepatide Versus Dulaglutide or Semaglutide on Major Cardiovascular Events in Type 2 Diabetes and Cardiovascular Disease: Insights From Two Target-Trial Emulations
Diabetes care;49(9):e163-e164
Comment on Klein et al. Safety of Semaglutide After Dialysis Initiation: An Individual-Level Pooled Analysis
Diabetes care;49(9):e159-e160
A noninvasive 13C-mannitol breath test to monitor semaglutide treatment-induced delayed oral-cecal transit in mice
American journal of physiology. Endocrinology and metabolism, 2026
Semaglutide Alleviates LPS-Induced Cognitive Disorder via O-GlcNAcylation of AKT-mTOR Signaling Pathway Components
Neuromolecular medicine, 2026;28(1)
Oral semaglutide vs DPP-4 inhibitors in reducing risk of cognitive impairment in elderly patients with HFpEF and obesity
Internal and emergency medicine, 2026
Oral semaglutide for obesity: clarifying comparative evidence and real-world applicability
Postgraduate medicine, 2026;:1-2
Glucagon-like peptide-1 receptor agonists in idiopathic intracranial hypertension: A systematic review and meta-analysis
Headache, 2026
Weekly Journal Scan: SURMOUNT and MAINTAIN the summit: tirzepatide after successful bodyweight loss
European heart journal, 2026